HSCT
FDA Approves Prevymis for CMV Prevention in Allo-HCT Patients
The FDA approved Merck's Prevymis, Merck for prophylaxis of cytomegalovirus infection and disease in adult ...
NOVEMBER 13, 2017
First-of-Its-Kind Therapy Approved for Hepatic VOD
The therapy was approved to treat adults and children who develop hepatic veno-occlusive disease with ...
MARCH 30, 2016
Load more